BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26739722)

  • 21. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam.
    Cuong do D; Thorson A; Sönnerborg A; Hoa NP; Chuc NT; Phuc HD; Larsson M
    Scand J Infect Dis; 2012 Mar; 44(3):201-8. PubMed ID: 22122590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
    Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
    HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era.
    Lartey M; Asante-Quashie A; Essel A; Kenu E; Ganu V; Neequaye A
    Ghana Med J; 2015 Mar; 49(1):7-11. PubMed ID: 26339078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in perimortal conditions and mortality rates among HIV-infected patients.
    Hooshyar D; Hanson DL; Wolfe M; Selik RM; Buskin SE; McNaghten AD
    AIDS; 2007 Oct; 21(15):2093-100. PubMed ID: 17885300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.
    Amogne W; Aderaye G; Habtewold A; Yimer G; Makonnen E; Worku A; Sonnerborg A; Aklillu E; Lindquist L
    PLoS One; 2015; 10(5):e0122587. PubMed ID: 25966339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Causes of death among 91 HIV-infected adults in the era of potent antiretroviral therapy].
    Sodqi M; Marih L; Lahsen AO; Bensghir R; Chakib A; Himmich H; El Filali KM
    Presse Med; 2012 Jul; 41(7-8):e386-90. PubMed ID: 22350063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.
    Mirani G; Williams PL; Chernoff M; Abzug MJ; Levin MJ; Seage GR; Oleske JM; Purswani MU; Hazra R; Traite S; Zimmer B; Van Dyke RB;
    Clin Infect Dis; 2015 Dec; 61(12):1850-61. PubMed ID: 26270680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.
    Podlekareva DN; Panteleev AM; Grint D; Post FA; Miro JM; Bruyand M; Furrer H; Obel N; Girardi E; Vasilenko A; Losso MH; Arenas-Pinto A; Caylá J; Rakhmanova A; Zeltina I; Werlinrud AM; Lundgren JD; Mocroft A; Kirk O;
    Eur Respir J; 2014 Jan; 43(1):166-77. PubMed ID: 23766333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration.
    Smith CJ; Ryom L; Weber R; Morlat P; Pradier C; Reiss P; Kowalska JD; de Wit S; Law M; el Sadr W; Kirk O; Friis-Moller N; Monforte Ad; Phillips AN; Sabin CA; Lundgren JD;
    Lancet; 2014 Jul; 384(9939):241-8. PubMed ID: 25042234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
    Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E
    Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda.
    Nansera D; Bajunirwe F; Elyanu P; Asiimwe C; Amanyire G; Graziano FM
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1371-6. PubMed ID: 22863182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
    Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
    Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.
    Moore D; Liechty C; Ekwaru P; Were W; Mwima G; Solberg P; Rutherford G; Mermin J
    AIDS; 2007 Mar; 21(6):713-9. PubMed ID: 17413692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Anglaret X; Yazdanpanah Y; Wang B; Toure S; Seage GR; N'Dri-Yoman T; Walensky RP; Dakoury-Dogbo N; Goldie SJ; Messou E; Weinstein MC; Deuffic-Burban S; Salamon R; Freedberg KA
    S Afr Med J; 2006 Jun; 96(6):526-9. PubMed ID: 16841136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Six-month survival of critically ill patients with HIV-related disease and tuberculosis: a retrospective study.
    Pecego AC; Amancio RT; Ribeiro C; Mesquita EC; Medeiros DM; Cerbino J; Grinsztejn B; Bozza FA; Japiassu AM
    BMC Infect Dis; 2016 Jun; 16():270. PubMed ID: 27286652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide data.
    Paula AA; Schechter M; Tuboi SH; Faulhaber JC; Luz PM; Veloso VG; Moreira RI; Grinsztejn B; Harrison LH; Pacheco AG
    PLoS One; 2014; 9(4):e94636. PubMed ID: 24728320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda.
    Moore DM; Yiannoutsos CT; Musick BS; Tappero J; Degerman R; Campbell J; Were W; Kaharuza F; Alexander LN; Downing R; Mermin J
    J Acquir Immune Defic Syndr; 2011 Nov; 58(3):289-96. PubMed ID: 21857358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes of deaths using verbal autopsy among adolescents and adults in rural western Kenya.
    van Eijk AM; Adazu K; Ofware P; Vulule J; Hamel M; Slutsker L
    Trop Med Int Health; 2008 Oct; 13(10):1314-24. PubMed ID: 18721187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.